133 related articles for article (PubMed ID: 11120841)
1. IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions.
Hussell T; Openshaw PJ
J Immunol; 2000 Dec; 165(12):7109-15. PubMed ID: 11120841
[TBL] [Abstract][Full Text] [Related]
2. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
Srikiatkhachorn A; Braciale TJ
J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
[TBL] [Abstract][Full Text] [Related]
3. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.
Hussell T; Georgiou A; Sparer TE; Matthews S; Pala P; Openshaw PJ
J Immunol; 1998 Dec; 161(11):6215-22. PubMed ID: 9834108
[TBL] [Abstract][Full Text] [Related]
4. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
Spender LC; Hussell T; Openshaw PJ
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
[TBL] [Abstract][Full Text] [Related]
5. CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease.
Olson MR; Varga SM
J Immunol; 2007 Oct; 179(8):5415-24. PubMed ID: 17911628
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.
Johnson TR; Rothenberg ME; Graham BS
J Leukoc Biol; 2008 Sep; 84(3):748-59. PubMed ID: 18519743
[TBL] [Abstract][Full Text] [Related]
7. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
8. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge.
Bembridge GP; Lopez JA; Bustos R; Melero JA; Cook R; Mason H; Taylor G
J Virol; 1999 Dec; 73(12):10086-94. PubMed ID: 10559323
[TBL] [Abstract][Full Text] [Related]
9. NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus.
Johnson TR; Hong S; Van Kaer L; Koezuka Y; Graham BS
J Virol; 2002 May; 76(9):4294-303. PubMed ID: 11932395
[TBL] [Abstract][Full Text] [Related]
10. CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV).
Hancock GE; Heers KM; Smith JD; Scheuer CA; Ibraghimov AR; Pryharski KS
Vaccine; 2001 Sep; 19(32):4874-82. PubMed ID: 11535341
[TBL] [Abstract][Full Text] [Related]
11. Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection.
Hussell T; Openshaw PJ
J Gen Virol; 1998 Nov; 79 ( Pt 11)():2593-601. PubMed ID: 9820134
[TBL] [Abstract][Full Text] [Related]
12. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.
Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G
J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246
[TBL] [Abstract][Full Text] [Related]
13. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus.
Tebbey PW; Hagen M; Hancock GE
J Exp Med; 1998 Nov; 188(10):1967-72. PubMed ID: 9815273
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.
Harker JA; Godlee A; Wahlsten JL; Lee DC; Thorne LG; Sawant D; Tregoning JS; Caspi RR; Bukreyev A; Collins PL; Openshaw PJ
J Virol; 2010 Apr; 84(8):4073-82. PubMed ID: 20130064
[TBL] [Abstract][Full Text] [Related]
15. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
Cyr SL; Jones T; Stoica-Popescu I; Brewer A; Chabot S; Lussier M; Burt D; Ward BJ
Vaccine; 2007 Jul; 25(29):5378-89. PubMed ID: 17561317
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.
Moore ML; Chi MH; Goleniewska K; Durbin JE; Peebles RS
Viral Immunol; 2008 Sep; 21(3):327-39. PubMed ID: 18788941
[TBL] [Abstract][Full Text] [Related]
17. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
18. Improved effector activity and memory CD8 T cell development by IL-2 expression during experimental respiratory syncytial virus infection.
Chang J; Choi SY; Jin HT; Sung YC; Braciale TJ
J Immunol; 2004 Jan; 172(1):503-8. PubMed ID: 14688360
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: Eosinophils do not contribute to respiratory syncytial virus vaccine-enhanced disease.
Castilow EM; Legge KL; Varga SM
J Immunol; 2008 Nov; 181(10):6692-6. PubMed ID: 18981084
[TBL] [Abstract][Full Text] [Related]
20. The role of IFN in respiratory syncytial virus pathogenesis.
Durbin JE; Johnson TR; Durbin RK; Mertz SE; Morotti RA; Peebles RS; Graham BS
J Immunol; 2002 Mar; 168(6):2944-52. PubMed ID: 11884466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
